Castle IRB is an independent IRB service ready to review your next research study; specializing in gene therapy, cell therapy, and rare disease studies.
Working in close collaboration with our partner IBC service provider, Clinical Biosafety Services, we offer integrated, consistent, and timely regulatory committee reviews of your gene and cell therapy clinical research.
While gene and cell therapy and rare disease projects are our specialty, Castle IRB has subject matter experts and IRB members in place to provide IRB review of most types of research. Castle IRB services include:
Castle IRB provides exemplary client-service assistance with Study and Site start-up for Investigators and Sponsors/CROs. Concierge level support is available.